Back to
NORTHERN TRUST CORP
CHRS30 quarters
Position history for
NORTHERN TRUST CORP's holdings in COHERUS ONCOLOGY INC
Yes. Northern Trust holds 1,129,470 shares of CHRS (Coherus Oncology), worth $1.6M, as of its Q2 2026 13F filing. It increased the position by 215,670 shares (+23.6%) from Q1 2026. Northern Trust has held CHRS in every 13F on record since Q1 2019, 30 quarterly filings.
Current Value
$1.6M
Current Shares
1.1M
Total Value Change
-$7.5M
Total Shares Change
+464,851
Quarter-by-Quarter History
Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP